Learn More About The GLP-1 Consumers Audience Segment & Their Purchasing Behavior Circana Downloadable Report Early Days of a Revolution: How GLP-1s Are Already Changing Consumer Spending Our new report highlights the impact of GLP-1 use on consumer spending habits, particularly on food, beverages, and non-food products, and opportunities for CPG companies
The table below uses incidence data from SURMOUNT-1 (Jastreboff et al., NEJM 2022)
Additionally, MIC+B12 supports weight loss by boosting metabolism and aiding in the breakdown of fats, making it easier to maintain a healthy weight
We all strive to have that perfect, glowing complexion, but sometimes, no matter how many beauty products we try, our skin just doesn't seem to cooperate
The webcast will begin at About the Phase 2b Study 1 The phase 2b study was a 26-week, randomized, placebo-controlled study comparing the effects of four doses (1 mg, 5 mg, 10 mg, 15 mg) of Lilly's novel long-acting dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist to dulaglutide 1.5 mg and placebo in people with type 2 diabetes